[REQ_ERR: 404] [KTrafficClient] Something is wrong. Enable debug mode to see the reason.
Color brca
No information is available for this page. Discover A Treatment Option For Patients With Metastatic Breast Cancer. AdLearn About An FDA-Approved MBC Chemotherapy Treatment Option. 1 thg 9, According to National Comprehensive Cancer Network,1 testing is indicated if one of the features mentioned below is present in the family: early. The Color BRCA and Lynch Test analyzes the two most common causes of hereditary breast and ovarian cancer, BRCA1 and BRCA2, as well as the five genes. Nov 18, Color's clinical-grade tests are ordered by a physician who reviews your information to decide if testing is right for you — or your own . Patients who use Color will learn about their genetic risk for hereditary breast, ovarian, and other cancers. The Color BRCA and Lynch Test analyzes the two most common causes of hereditary breast and ovarian cancer, BRCA1 and BRCA2, as well as the five genes association with Lynch syndrome, MLH1, MSH2, MSH6, PMS2, and EPCAM*. Patients who use Color will learn about their genetic risk for hereditary breast, ovarian, and other cancers. The Color BRCA and Lynch Test analyzes the two most common causes of hereditary breast and ovarian cancer, BRCA1 and BRCA2, as well as the five genes association with Lynch syndrome, MLH1, MSH2, MSH6, PMS2, and EPCAM*. We will also confirm mutations, including in the BRCA1 and BRCA2 genes, from a direct to consumer test (like 23andme) or a mutation detected by third party analysis of raw data (like . For example, Color Genomics (Burlingame, CA) offers a DTC genetic test that analyzes 30 cancer susceptibility genes, including BRCA1 and. Test Overview: The Color Test analyzes 30 genes, including BRCA1 and BRCA2, to help women and men understand their risk for the most common hereditary.